A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs

• DOI: 10.1016/j.yrtph.2019.104522
• Publication Date: 2019-11-12T00:05:17Z
• Authors: Yonglin Gao; Guangfei Wang; Tong Wang; Guisheng Li; Jian Lin; Liqin Sun; Xuran Wu; Xilin Sun; Hongbo Wang; Chunmei Li; Jingwei Tian; Jing Zhu; Kezhou Wang; Susan Cho
• Keywords: Beagle; No-observed-adverse-effect level; Histopathology

20(s)-ginsenoside Rg3 is a red ginseng-derived compound with the formula C42H72O13 that has been increasingly used by humans, leading to safety concerns regarding this use. In the current study, we conducted a 26-week study during which 20(S)-ginsenoside Rg3 (0, 7, 20, or 60 mg/kg) was continuously administered orally to Beagle dogs in order to explore its toxicity in these animals, with control dogs receiving a vehicle capsule. In total, 10 dogs received each dose of this compound (n = 5 male, n = 5 female per dose). Animals were continuously monitored for a 26-week administration period and a subsequent 4-week follow-up recovery period. At the end of study, we observed no evidence of 20(S)-ginsenoside Rg3 toxicity in clinical indications, body weight, food intake, ophthalmoscopy, electrocardiogram, urinalysis, hematology, serum biochemistry, gross and histopathology findings. However, the kidney relative weight of animals receiving 60 mg/kg of compound was significantly elevated relative to control animals (5.15 ± 0.88‰ vs. 4.11 ± 0.59‰. P < 0.05), and this effect was reversed after 4-week recovery period. Based on these results, the NOAEL value for orally administered 20(S)-ginsenoside Rg3 in dogs is 20 mg/kg.